Health
New drug candidate to fight COVID-19 – Goondiwindi Argus
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
A drug described as potential new immunotherapy for COVID-19 will enter a clinical trial in the USA led by former Australian of the Year Professor Ian Frazer.
Developed by Brisbane and Seattle-based company, Implicit Bioscience, the drug IC14 will this week be tested in COVID-19 patients in 10-15 hospitals across the United States.
The new drug, for which Prof Frazer is the clinical immunologist and chief scientific officer, will treat immune responses to COVID-19 and its health complications.
Its…
-
General13 hours agoCoroner to examine treatment of woman who died three days after surgery performed by former Queensland premier’s partner
-
General16 hours agoAlbanese beats drum on economy as trade clouds gather
-
Noosa News15 hours agoSurgeon partner of former premier to testify over his patient’s death
-
Business13 hours agoWhy Antipa, Cettire, Magnetic Resources, and Steadfast shares are pushing higher